164 related articles for article (PubMed ID: 31539237)
1. Enhancing Cytotoxicity of a Monofunctional Platinum Complex via a Dual-DNA-Damage Approach.
Guo Y; He Y; Wu S; Zhang S; Song D; Zhu Z; Guo Z; Wang X
Inorg Chem; 2019 Oct; 58(19):13150-13160. PubMed ID: 31539237
[TBL] [Abstract][Full Text] [Related]
2. Anticancer Activity of Platinum (II) Complex with 2-Benzoylpyridine by Induction of DNA Damage, S-Phase Arrest, and Apoptosis.
Li YL; Gan XL; Zhu RP; Wang X; Liao DF; Jin J; Huang Z
Anticancer Agents Med Chem; 2020; 20(4):504-517. PubMed ID: 31721706
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, spectroscopic and biological studies of a fluorescent Pt(II) (terpy) based 1,8-naphthalimide conjugate as a DNA targeting agent.
Banerjee S; Kitchen JA; Bright SA; O'Brien JE; Williams DC; Kelly JM; Gunnlaugsson T
Chem Commun (Camb); 2013 Oct; 49(76):8522-4. PubMed ID: 23942760
[TBL] [Abstract][Full Text] [Related]
4. DNA topoisomerases as additional targets for anticancer monofunctional platinum(ii) complexes.
Zhang H; Yang T; Wang Y; Wang Z; Zhu Z; Guo Z; Wang X
Dalton Trans; 2021 Jan; 50(1):304-310. PubMed ID: 33300919
[TBL] [Abstract][Full Text] [Related]
5. Photodamaging of Mitochondrial DNA to Overcome Cisplatin Resistance by a Ru
Zheng Y; Zhang DY; Zhang H; Cao JJ; Tan CP; Ji LN; Mao ZW
Chemistry; 2018 Dec; 24(71):18971-18980. PubMed ID: 30264929
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of a new series of low toxic naphthalimide platinum(IV) antitumor complexes with dual DNA damage mechanism.
Wang Q; Tan X; Liu Z; Li G; Zhang R; Wei J; Wang S; Li D; Wang B; Han J
Eur J Pharm Sci; 2018 Nov; 124():127-136. PubMed ID: 30153524
[TBL] [Abstract][Full Text] [Related]
7. Terpyridine-platinum(II) complexes are effective inhibitors of mammalian topoisomerases and human thioredoxin reductase 1.
Lo YC; Ko TP; Su WC; Su TL; Wang AH
J Inorg Biochem; 2009 Jul; 103(7):1082-92. PubMed ID: 19525010
[TBL] [Abstract][Full Text] [Related]
8. Pyriplatin-Boron-Dipyrromethene Conjugates for Imaging and Mitochondria-Targeted Photodynamic Therapy.
Raza MK; Gautam S; Howlader P; Bhattacharyya A; Kondaiah P; Chakravarty AR
Inorg Chem; 2018 Nov; 57(22):14374-14385. PubMed ID: 30376306
[TBL] [Abstract][Full Text] [Related]
9. 1,8-Naphthalimide: A Potent DNA Intercalator and Target for Cancer Therapy.
Tandon R; Luxami V; Kaur H; Tandon N; Paul K
Chem Rec; 2017 Oct; 17(10):956-993. PubMed ID: 28375569
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and analysis of the anticancer activity of platinum(II) complexes incorporating dipyridoquinoxaline variants.
Pages BJ; Li F; Wormell P; Ang DL; Clegg JK; Kepert CJ; Spare LK; Danchaiwijit S; Aldrich-Wright JR
Dalton Trans; 2014 Nov; 43(41):15566-75. PubMed ID: 25197979
[TBL] [Abstract][Full Text] [Related]
11. Oxidative DNA double strand breaks and autophagy in the antitumor effect of sterically hindered platinum(II) complexes in NSCLCs.
Chen F; Wang X; Jin X; Zhao J; Gou S
Oncotarget; 2017 May; 8(19):30933-30955. PubMed ID: 28427237
[TBL] [Abstract][Full Text] [Related]
12. Targeting Energy Metabolism by a Platinum(IV) Prodrug as an Alternative Pathway for Cancer Suppression.
Jin S; Guo Y; Song D; Zhu Z; Zhang Z; Sun Y; Yang T; Guo Z; Wang X
Inorg Chem; 2019 May; 58(9):6507-6516. PubMed ID: 31013065
[TBL] [Abstract][Full Text] [Related]
13. A potent aminonaphthalimide platinum(IV) complex with effective antitumor activities in vitro and in vivo displaying dual DNA damage effects on tumor cells.
Wang Q; Chen Y; Li G; Zhao Y; Liu Z; Zhang R; Liu M; Li D; Han J
Bioorg Med Chem Lett; 2019 Oct; 29(20):126670. PubMed ID: 31500997
[TBL] [Abstract][Full Text] [Related]
14. A Pt(IV)-based mononitro-naphthalimide conjugate with minimized side-effects targeting DNA damage response via a dual-DNA-damage approach to overcome cisplatin resistance.
Li Y; Yue K; Li L; Niu J; Liu H; Ma J; Xie S
Bioorg Chem; 2020 Aug; 101():104011. PubMed ID: 32599363
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Biological Evaluation of Ru(II) and Pt(II) Complexes Bearing Carboxyl Groups as Potential Anticancer Targeted Drugs.
Martínez MÁ; Carranza MP; Massaguer A; Santos L; Organero JA; Aliende C; de Llorens R; Ng-Choi I; Feliu L; Planas M; Rodríguez AM; Manzano BR; Espino G; Jalón FA
Inorg Chem; 2017 Nov; 56(22):13679-13696. PubMed ID: 29099179
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antitumor activities of three novel binuclear platinum(II) complexes with 4'-substituted-2,2':6',2″-terpyridine ligands.
Qin QP; Wang ZF; Wang SL; Luo DM; Zou BQ; Yao PF; Tan MX; Liang H
Eur J Med Chem; 2019 May; 170():195-202. PubMed ID: 30897397
[TBL] [Abstract][Full Text] [Related]
17. l,8-Naphthalimide based DNA intercalators and anticancer agents. A systematic review from 2007 to 2017.
Tomczyk MD; Walczak KZ
Eur J Med Chem; 2018 Nov; 159():393-422. PubMed ID: 30312931
[TBL] [Abstract][Full Text] [Related]
18. Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents.
Zhang Z; Wang X; Luo C; Zhu C; Wang K; Zhang C; Guo Z
Chem Asian J; 2017 Jul; 12(13):1659-1667. PubMed ID: 28556606
[TBL] [Abstract][Full Text] [Related]
19. Palladium(ii) and platinum(ii) saccharinate complexes with bis(diphenylphosphino)methane/ethane: synthesis, S-phase arrest and ROS-mediated apoptosis in human colon cancer cells.
Icsel C; Yilmaz VT; Aygun M; Cevatemre B; Alper P; Ulukaya E
Dalton Trans; 2018 Aug; 47(33):11397-11410. PubMed ID: 30062356
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and antitumor evaluation of new 1,8-naphthalimide derivatives targeting nuclear DNA.
Liang GB; Wei JH; Jiang H; Huang RZ; Qin JT; Wang HL; Wang HS; Zhang Y
Eur J Med Chem; 2021 Jan; 210():112951. PubMed ID: 33109400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
